The Annual Review of Pharmacology and Toxicology· 2015Q1· Review
MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective
- 630citations
- Q1SCImago
- 2015year
Short summary
Melatonin's beneficial effects on sleep, mood, and neuroprotection are mediated through MT1 and MT2 receptors, leading to the development of novel agonists like agomelatine and ramelteon for treating insomnia, circadian disorders, and other conditions.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Endocrine and Autonomic Systems
Endocrine and Autonomic SystemsNeuroscience